Robert W Buchanan

Robert W Buchanan

UNVERIFIED PROFILE

Are you Robert W Buchanan?   Register this Author

Register author
Robert W Buchanan

Robert W Buchanan

Publications by authors named "Robert W Buchanan"

Are you Robert W Buchanan?   Register this Author

98Publications

2497Reads

23Profile Views

Intranasal oxytocin enhances EEG mu rhythm desynchronization during execution and observation of social action: An exploratory study.

Psychoneuroendocrinology 2020 Jan 5;111:104467. Epub 2019 Oct 5.

Department of Human Development and Quantitative Methodology, University of Maryland, College Park, MD 20740, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psyneuen.2019.104467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897365PMC
January 2020

Nicotine effects on cognitive remediation training outcome in people with schizophrenia: A pilot study.

Psychiatry Res 2019 10 29;280:112498. Epub 2019 Jul 29.

Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2019.112498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756954PMC
October 2019

The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness.

Transl Psychiatry 2019 09 16;9(1):229. Epub 2019 Sep 16.

Northwestern University Department of Psychology, Department of Psychiatry, Department of Medical Social Sciences, Institute for Policy Research, and Institute for Innovations in Developmental Sciences, Evanston, IL, 60208, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41398-019-0563-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746855PMC
September 2019

The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.

Psychol Med 2019 07 5;49(10):1731-1739. Epub 2018 Sep 5.

Department of Psychiatry,Maryland Psychiatric Research Center, University of Maryland School of Medicine,Baltimore, MD,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0033291718002465DOI Listing
July 2019

Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness.

Am J Psychiatry 2019 07 4;176(7):521-530. Epub 2019 Jan 4.

Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto (Hawco, Calarco, Mulsant, Viviano, Dickie, Foussias, Voineskos); the Department of Psychiatry, University of Toronto, Toronto (Hawco, Foussias, Mulsant, Voineskos); Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Md. (Buchanan, Gold); Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, N.Y. (Argyelan, DeRosse, Malhotra); Zucker School of Medicine at Hofstra/Northwell, Hempstead, N.Y. (Argyelan, DeRosse, Malhotra); the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (Iacoboni).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2018.17091020DOI Listing
July 2019

Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study

J Psychiatry Neurosci 2019 07;44(4):269-276

From the Maryland Psychiatric Research Center (MPRC), School of Medicine, University of Maryland, College Park, MD (Kelly, McMahon, August, Feldman, Liu, Powell, Wehring, Buchanan, Gold, Carpenter); the Department of Orthopedics, School of Medicine, University of Maryland, College Park, MD (Demyanovich); the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Rodriguez, Eaton); the Department of Pathology, Division of Immunology, Immune Disorders Laboratory, Johns Hopkins University, Baltimore, MD (Cˇiháková, Talor); the Spring Grove Hospital Center, Baltimore, MD (Richardson, Vyas, Adams); the Center for Celiac Research and Treatment, Massachusetts General Hospital, Boston, MA (Fasano); the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD (Cascella); the Department of Psychology, Kent State University, Kent, OH (Sayer).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606425PMC
July 2019

Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia.

J Psychiatr Res 2019 05 25;112:38-43. Epub 2019 Feb 25.

University of Maryland School of Medicine, Department of Psychiatry and Maryland Psychiatric Research Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2019.02.017DOI Listing
May 2019

The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report.

J Psychiatr Brain Sci 2019 9;4(1). Epub 2019 Jan 9.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20900/jpbs.20190001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485966PMC
January 2019

A longitudinal human phantom reliability study of multi-center T1-weighted, DTI, and resting state fMRI data.

Psychiatry Res Neuroimaging 2018 12 9;282:134-142. Epub 2018 Jun 9.

Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2018.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482446PMC
December 2018

Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects.

Biol Psychiatry 2018 11 13;84(9):665-674. Epub 2018 Apr 13.

Kimel Family Translational Imaging-Genetics Research Lab, Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario; Department of Psychiatry, University of Toronto, Toronto, Ontario. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2018.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177285PMC
November 2018

Increased circulating regulatory T cells in medicated people with schizophrenia.

Psychiatry Res 2018 11 5;269:517-523. Epub 2018 Sep 5.

Laboratory of Behavioral Neuroimmunology, Department of Psychiatry, University of Maryland School of Medicine, 685 West Baltimore Street, MSTF Building Room 934 E, Baltimore 21201, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2018.09.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207456PMC
November 2018

Negative symptoms of schizophrenia: new developments and unanswered research questions.

Lancet Psychiatry 2018 08 27;5(8):664-677. Epub 2018 Mar 27.

Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Centro de Investigación en Red de Salud Mental, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(18)30050-6DOI Listing
August 2018

Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia.

Schizophr Res 2018 07 27;197:156-161. Epub 2018 Feb 27.

University of Maryland School of Medicine, Department of Psychiatry, Maryland Psychiatric Research Center, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09209964183009
Publisher Site
http://dx.doi.org/10.1016/j.schres.2018.02.016DOI Listing
July 2018

Effects of a nicotinic agonist on the Brief Psychiatric Rating Scale five-factor subscale model in schizophrenia.

Schizophr Res 2018 05 16;195:568-569. Epub 2017 Oct 16.

Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.10.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476180PMC
May 2018

Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups.

J Psychiatr Res 2018 02 12;97:8-15. Epub 2017 Nov 12.

Department of Psychiatry, University of Maryland School of Medicine, Maryland Psychiatric Research Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2017.11.004DOI Listing
February 2018

A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.

J Clin Psychopharmacol 2017 Aug;37(4):394-400

From the *Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD; †Department of Psychology, University of Georgia, Athens, GA; and ‡Department of Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484721PMC
August 2017

Negative Symptom Therapeutics.

Schizophr Bull 2017 07;43(4):681-682

Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbx054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472112PMC
July 2017

Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.

Schizophr Res 2017 04 24;182:90-97. Epub 2016 Oct 24.

Semel Institute for Neuroscience at UCLA, Los Angeles, CA, United States; VA Desert Pacific Mental Illness Research, Education, and Clinical Center, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09209964163047
Publisher Site
http://dx.doi.org/10.1016/j.schres.2016.10.027DOI Listing
April 2017

Neural Activity while Imitating Emotional Faces is Related to Both Lower and Higher-Level Social Cognitive Performance.

Sci Rep 2017 04 28;7(1):1244. Epub 2017 Apr 28.

Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College St., Toronto, M5T 1R8, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-01316-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430668PMC
April 2017

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Am J Psychiatry 2017 Mar 6;174(3):216-229. Epub 2016 Dec 6.

From King's College London, Institute of Psychiatry, Psychology, and Neuroscience; MRC Clinical Sciences Centre; Institute of Clinical Sciences, Imperial College, and Hammersmith Hospital London; the Department of Psychiatry, University of Toronto, and the Centre for Addiction and Mental Health, Toronto; the Section of Psychiatry and Treatment Resistant Psychosis and the Laboratory of Translational Psychiatry, School of Medicine of Naples Federico II, Naples; the Departments of Psychiatry and Neuroscience, Erasmus Medical Center, and Antes Mental Health Care, Rotterdam, the Netherlands; the Feinstein Institute for Medical Research, Psychiatry Research, Zucker Hillside Hospital, Hofstra Northwell School of Medicine; the Division of Psychiatry, University College London; Laboratorio Interdisciplinar de Neurociencia Clinica, Universidade Federal de São Paulo, São Paulo; the Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore; the University of Melbourne and St. Vincent's Hospital, Sydney; the Department of Psychiatry and Behavioral Sciences, New York Medical College, New York; the Department of Psychiatry, Tel Aviv University, Tel Aviv; the Division of Health Sciences, School of Psychology and Mental Health, Faculty of Biology, Medicine, and Health, University of Manchester, and the Manchester Academic Health Science Centre, Manchester Mental Health and Social Care NHS Trust, Manchester; the Department of Psychiatry, University of Alberta, Edmonton; the Center for Neuropsychiatric Schizophrenia Research and the Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Mental Health Center Glostrup, University of Copenhagen, Copenhagen; the Department of Psychiatry, University of São Paulo Medical School, São Paulo; the Department of Psychiatry, University of Munich, Munich; the Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck, Innsbruck, Austria; Programa de Esquizofrenia and Laboratorio Interdisciplinar de Neurociencia Clinica, Universidade Federal de São Paulo, São Paulo; the National Psychosis Service, South London and Maudsley NHS Foundation Trust; the Neuroscience and Behavior Department, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo; the Department of Psychiatry, University of British Columbia; Lundbeck LLC, Deerfield, Ill.; University Department of Psychiatry, Royal Edinburgh Hospital, Edinburgh; the Department of General Psychiatry, Institute of Mental Health, Singapore; the Deparment of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg; the Brain and Mind Centre, University of Sydney, Sydney; the School of Pharmacy, University of Auckland, Auckland, New Zealand; the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago; the Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich; the Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo; the Department of Psychiatry, Melbourne Neuropsychiatry Centre, University of Melbourne, and Melbourne Health, Victoria; the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto; the Centre for Mental Health, Swinburne University, the Monash Alfred Psychiatry Research Centre, and the Department of Psychiatry, St. Vincent's Hospital Melbourne, Sydney; the School of Pharmacy, University of Otago, Otago, New Zealand; COS and Associates Ltd., Hong Kong; the Department of Neuropsychiatry, Keio University School of Medicine, Keio, Japan; the Department of Neuroscience, University Medical Center Utrecht, Utrecht, the Netherlands; Swinburne University and Monash Alfred Psychiatry Research Centre, Brain and Psychological Sciences Research Centre, Melbourne; the Istanbul Faculty of Medicine, Istanbul University, Istanbul; Clinical Research and Early Development, F. Hoffmann -La Roche Ltd., Basel, Switzerland; the Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, and the MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff; Psychiatry Research, Zucker Hillside Hospital, Long Island Jewish Medical Center, Hofstra Northwell School of Medicine, and the Feinstein Institute for Medical Research, New York.

View Article

Download full-text PDF

Source
http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.16
Publisher Site
http://dx.doi.org/10.1176/appi.ajp.2016.16050503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231547PMC
March 2017

The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.

Psychiatr Serv 2016 12 1;67(12):1300-1306. Epub 2016 Jul 1.

Dr. Kreyenbuhl, Dr. Medoff, and Dr. Hackman are with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore (e-mail: ). Dr. Kreyenbuhl and Dr. Medoff are also with the Mental Illness Research, Education and Clinical Center, Department of Veterans Affairs Capitol Healthcare Network (VISN 5), Baltimore. Dr. McEvoy is with the Department of Psychiatry, Medical College of Georgia, Augusta University, Augusta. Dr. Smith, Dr. Nossel, Dr. Dixon, and Dr. Essock are with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and with the New York State Psychiatric Institute, New York City. Dr. Buchanan is with the Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.201500438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633208PMC
December 2016

Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial.

Prog Neuropsychopharmacol Biol Psychiatry 2016 11 28;71:66-75. Epub 2016 Jun 28.

Novartis Pharma AG, Basel, Switzerland; Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2016.06.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432789PMC
November 2016

Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.

Schizophr Bull 2015 Sep 3;41(5):1045-54. Epub 2015 Jul 3.

Department of Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, CA; UCLA Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine, Los Angeles, CA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbv089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535649PMC
September 2015

Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates.

Schizophr Bull 2015 Sep 23;41(5):1055-65. Epub 2015 Jul 23.

Department of Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, CA; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, Los Angeles, CA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbv090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535650PMC
September 2015

Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

J Clin Psychopharmacol 2015 Aug;35(4):374-81

From the *Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD; †Department of Psychiatry, Georgia Regents University, Medical College of Georgia, Augusta, GA; ‡Department of Psychiatry, Clinical Research Program, Sheppard Pratt Health System and University of Maryland School of Medicine, Baltimore, MD; and §Department of Psychiatry, Psychology and Neuroscience, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/psychopharmacology/2015/08000/A
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/JCP.0000000000000345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485552PMC
August 2015

Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia.

JAMA Psychiatry 2015 Aug;72(8):745-6

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamapsychiatry.2015.0485DOI Listing
August 2015

Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.

Schizophr Bull 2015 Jul 2;41(4):900-8. Epub 2014 Nov 2.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbu151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466175PMC
July 2015

Practical Monitoring of Treatment Fidelity: Examples From a Team-Based Intervention for People With Early Psychosis.

Psychiatr Serv 2015 Jul 2;66(7):674-6. Epub 2015 Jan 2.

Dr. Essock, Dr. Nossel, and Dr. Dixon are with the New York State Psychiatric Institute and the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York City (e-mail: ). Dr. McNamara, Dr. Bennett, Dr. Kreyenbuhl, and Dr. Goldman are with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore. Dr. Buchanan is with the Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore. Ms. Mendon is with the New York State Psychiatric Institute, New York City. Marcela Horvitz-Lennon, M.D., M.P.H., is editor of this column. This column is part of a special section on RAISE and other early intervention services.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.201400531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490109PMC
July 2015

Evidence-based early interventions for individuals at clinical high risk for psychosis: a review of treatment components.

J Nerv Ment Dis 2015 May;203(5):342-51

*Department of Psychology, University of Maryland, Baltimore County; †Division of Child and Adolescent Psychiatry, University of Maryland, Baltimore; ‡Department of Psychology and Neuroscience, University of Colorado at Boulder; and §School of Social Work and ∥Maryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NMD.0000000000000287DOI Listing
May 2015

Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.

Schizophr Res 2015 Mar 9;162(1-3):57-61. Epub 2015 Jan 9.

Maryland Psychiatric Research center and Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09209964140075
Publisher Site
http://dx.doi.org/10.1016/j.schres.2014.12.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339311PMC
March 2015

Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.

Schizophr Res 2015 Mar 22;162(1-3):52-6. Epub 2015 Jan 22.

University of Maryland School of Medicine, Department of Psychiatry and Maryland Psychiatric Research Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2015.01.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339450PMC
March 2015

Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.

Schizophr Res 2015 Mar 9;162(1-3):47-51. Epub 2015 Feb 9.

University of Maryland School of Medicine, Department of Psychiatry and Maryland Psychiatric Research Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2015.01.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339097PMC
March 2015

Early intervention: how early and with what?

Schizophr Bull 2015 Jan 14;41(1):4-5. Epub 2014 Nov 14.

Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbu160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266312PMC
January 2015

Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Psychopharmacology (Berl) 2014 Sep 17;231(17):3647-62. Epub 2014 Jul 17.

Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-014-3673-4DOI Listing
September 2014

Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia.

Schizophr Res 2014 Aug 28;157(1-3):84-9. Epub 2014 May 28.

Sheppard Pratt Health System, Baltimore, MD, USA; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2014.04.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099270PMC
August 2014

William T. Carpenter Jr: 35 years of clinical trials.

Schizophr Bull 2014 Mar;40 Suppl 2:S160-3

*To whom correspondence should be addressed; Department of Psychiatry, Maryland Psychiatric Research Center, PO Box 21247, Baltimore, MD 21228, US.

View Article

Download full-text PDF

Source
https://academic.oup.com/schizophreniabulletin/article-looku
Publisher Site
http://dx.doi.org/10.1093/schbul/sbt143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934409PMC
March 2014

Celebrating the work of William T. Carpenter Jr.

Schizophr Bull 2014 Mar;40 Suppl 2:S95-6

*To whom correspondence should be addressed; Department of Psychiatry, University of Maryland School of Medicine, 655 West Baltimore Street, Suite 14-009, Baltimore, MD 21201, US; tel: 410-706-1412; fax: 410-706-1414.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbt204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934396PMC
March 2014

Community adherence to schizophrenia treatment and safety monitoring guidelines.

J Nerv Ment Dis 2014 Jan;202(1):6-12

*Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore; and †VA Capital Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NMD.0000000000000093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228984PMC
January 2014

Research and services partnerships: the practice research network: a successful collaboration in Maryland.

Psychiatr Serv 2013 May;64(5):407-9

Department of Psychiatry, University of Maryland School of Medicine, 1501 South Edgewood St., Suite L, Baltimore, MD 21227, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.201300015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115578PMC
May 2013

A review of anti-inflammatory agents for symptoms of schizophrenia.

J Psychopharmacol 2013 Apr 13;27(4):337-42. Epub 2012 Nov 13.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881112467089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641824PMC
April 2013

Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?

Schizophr Bull 2013 Mar 22;39(2):417-35. Epub 2011 Nov 22.

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbr153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576170PMC
March 2013

The potential of nicotinic enhancement of cognitive remediation training in schizophrenia.

Neuropharmacology 2013 Jan 13;64:185-90. Epub 2012 Jun 13.

University of Maryland School of Medicine, Maryland Psychiatric Research Center, P.O. Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00283908120025
Publisher Site
http://dx.doi.org/10.1016/j.neuropharm.2012.05.050DOI Listing
January 2013

Factor structure of the Brief Negative Symptom Scale.

Schizophr Res 2012 Dec 9;142(1-3):96-8. Epub 2012 Oct 9.

University of Maryland School of Medicine, Department of Psychiatry and Maryland Psychiatric Research Center, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2012.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502636PMC
December 2012

Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

Schizophr Res 2012 Dec 3;142(1-3):88-92. Epub 2012 Nov 3.

University of Maryland School of Medicine, Department of Psychiatry and Maryland Psychiatric Research Center, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2012.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502630PMC
December 2012

Cortical structural abnormalities in deficit versus nondeficit schizophrenia.

Schizophr Res 2012 Apr 13;136(1-3):51-4. Epub 2012 Feb 13.

Veterans Affairs Capital Network (VISN 5) Mental Illness Research, Education, and Clinical Center, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2012.01.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298625PMC
April 2012

Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia.

Schizophr Res 2012 Mar 29;135(1-3):134-8. Epub 2011 Nov 29.

Department of Psychiatry, University of Maryland School of Medicine, Maryland Psychiatric Research Center, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S092099641100601
Publisher Site
http://dx.doi.org/10.1016/j.schres.2011.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288761PMC
March 2012

Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia.

J Clin Psychopharmacol 2012 Feb;32(1):36-45

Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0b013e31823f880aDOI Listing
February 2012

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.

J Clin Psychiatry 2012 Jan 5;73(1):95-102. Epub 2011 Apr 5.

The Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://article.psychiatrist.com/?ContentType=START&ID=10
Publisher Site
http://dx.doi.org/10.4088/JCP.10m06143greDOI Listing
January 2012

The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?

Schizophr Bull 2011 Nov 21;37(6):1209-17. Epub 2010 Apr 21.

Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbq038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196938PMC
November 2011

Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.

Clin Schizophr Relat Psychoses 2011 Apr;5(1):17-25

Maryland Psychiatric Research Center, University of Maryland School of Medicine,Catonsville, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3371/CSRP.5.1.3DOI Listing
April 2011

Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program.

Schizophr Res 2011 Mar 26;126(1-3):277-83. Epub 2010 Nov 26.

VA Capitol Network (VISN 5) Mental Illness, Research Education and Clinical Center (MIRECC), VA Maryland Health Care System (VAMHCS), 10 N. Greene St., Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2010.10.030DOI Listing
March 2011

α7 Nicotinic receptor agonists as cognitive treatments: is less (or less often) more?

Biol Psychiatry 2011 Jan;69(1):5-6

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2010.11.004DOI Listing
January 2011

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.

Neuropsychopharmacology 2010 Oct 21;35(11):2274-83. Epub 2010 Jul 21.

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npp.2010.101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939921PMC
October 2010

Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.

Neuropsychopharmacology 2010 Feb 4;35(3):632-40. Epub 2009 Nov 4.

Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/npp2009168
Publisher Site
http://dx.doi.org/10.1038/npp.2009.168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055615PMC
February 2010

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

Schizophr Bull 2010 Jan 2;36(1):94-103. Epub 2009 Dec 2.

VA Capitol Health care Network (VISN 5) Mental Illness Research, Education, and Clinical Center, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbp130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800150PMC
January 2010

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Schizophr Bull 2010 Jan 2;36(1):71-93. Epub 2009 Dec 2.

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbp116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800144PMC
January 2010

The effects of galantamine on psychopathology in chronic stable schizophrenia.

Clin Neuropharmacol 2009 Mar-Apr;32(2):69-74

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0B013E31816F2795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049075PMC
September 2009

White matter alterations in deficit schizophrenia.

Neuropsychopharmacology 2009 May 3;34(6):1514-22. Epub 2008 Dec 3.

Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npp.2008.207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669692PMC
May 2009

A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.

J Clin Psychiatry 2009 Apr 7;70(4):518-25. Epub 2009 Apr 7.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.08m04358DOI Listing
April 2009

Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate.

Arch Gen Psychiatry 2008 Sep;65(9):1008-16

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archpsyc.65.9.1008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774756PMC
September 2008